TA
BMRN icon

Teachers Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Teachers Advisors’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$78.1M Buy
879,474
+49,662
+6% +$4.6M 0.1% 225
2018
Q4 		$70.7M Buy
829,812
+49,909
+6% +$4.75M 0.1% 213
2018
Q3 		$75.6M Buy
779,903
+126,415
+19% +$12.6M 0.09% 241
2018
Q2 		$61.6M Buy
653,488
+1,633
+0.3% +$143K 0.08% 295
2018
Q1 		$52.8M Sell
651,855
-250,009
-28% -$21.5M 0.07% 333
2017
Q4 		$80.4M Sell
901,864
-65,790
-7% -$5.72M 0.1% 223
2017
Q3 		$90.1M Sell
967,654
-5,637
-0.6% -$498K 0.12% 190
2017
Q2 		$88.4M Buy
973,291
+286,249
+42% +$26M 0.12% 194
2017
Q1 		$60.3M Buy
687,042
+123,833
+22% +$11M 0.09% 294
2016
Q4 		$46.7M Sell
563,209
-47,975
-8% -$4.13M 0.07% 320
2016
Q3 		$56.5M Buy
611,184
+91,069
+18% +$8.58M 0.09% 267
2016
Q2 		$40.5M Sell
520,115
-35,204
-6% -$2.99M 0.07% 335
2016
Q1 		$45.8M Buy
555,319
+10,306
+2% +$839K 0.08% 296
2015
Q4 		$57.1M Buy
545,013
+111,056
+26% +$11.6M 0.11% 239
2015
Q3 		$45.7M Sell
433,957
-219,505
-34% -$29.3M 0.09% 278
2015
Q2 		$89.4M Buy
653,462
+50,185
+8% +$6.22M 0.17% 126
2015
Q1 		$75.2M Buy
603,277
+88,291
+17% +$9.35M 0.14% 179
2014
Q4 		$46.6M Buy
514,986
+200,673
+64% +$16.7M 0.09% 298
2014
Q3 		$22.7M Buy
314,313
+222,032
+241% +$14.6M 0.05% 487
2014
Q2 		$5.74M Buy
92,281
+6,767
+8% +$409K 0.01% 1087
2014
Q1 		$5.83M Buy
85,514
+2,192
+3% +$162K 0.01% 1042
2013
Q4 		$5.86M Sell
83,322
-232,950
-74% -$15.8M 0.01% 1028
2013
Q3 		$22.8M Sell
316,272
-147,108
-32% -$9.78M 0.06% 447
2013
Q2 		$25.9M Buy
+463,380
New +$28.9M 0.07% 364

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Teachers Advisors's BMRN Position: Q1 2019 in Review

Teachers Advisors increased its BioMarin Pharmaceuticals (BMRN) stake by 6% in Q1 2019, buying an estimated $4.6M and bringing the position to 879,474 shares worth $78.1M. The position accounts for 0.1% of the portfolio, ranked #225.

Teachers Advisors first reported a position in BMRN in Q2 2013 and has held it in 24 quarters since. The position peaked at $90.1M in Q3 2017. 485 funds tracked by Wall St. Rank hold BMRN as of Q1 2019.

  • Teachers Advisors held 879,474 shares of BioMarin Pharmaceuticals worth $78.1M as of Q1 2019.
  • Teachers Advisors bought 49,662 BioMarin Pharmaceuticals shares in Q1 2019, an estimated $4.6M.
  • BioMarin Pharmaceuticals made up 0.1% of Teachers Advisors's portfolio in Q1 2019, its #225 holding.
  • Teachers Advisors first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 24 quarters since.
  • Teachers Advisors's BioMarin Pharmaceuticals position peaked at $90.1M in Q3 2017.
  • 485 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.